Stock DBI DEUTSCHE BIOTECH INNOVATIV AG
Add to a list
To use this feature you must be a member
Log inSign up

News Deutsche Biotech Innovativ AG Xetra

Equities

DBI

DE000A0Z25L1

Delayed Xetra
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Deutsche Biotech Innovativ AG -.--% -69.04%
2023 Deutsche Biotech Innovativ AG Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2018 Adrenomed AG announced that it has received €24.2 million in funding from Deutsche Biotech Innovativ AG, Wellington Ventures, HBM Healthcare Investments Ltd., and other investors CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Deutsche Biotech Innovativ AG Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Adrenomed AG announced that it has received €24.2 million in funding from Deutsche Biotech Innovativ AG, Wellington Ventures, HBM Healthcare Investments Ltd., and other investors
CI
Deutsche Biotech Innovativ AG Completes Preclinical Studies with Adrecizumab, an Innovative Drug Candidate for Treating Sepsis
CI
Deutsche Biotech Innovativ AG Successful Further Development of Sepsis and Cancer Drugs
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DBI Stock
  4. DBI Stock
  5. News Deutsche Biotech Innovativ AG